323 related articles for article (PubMed ID: 24795292)
1. Changing roles of eosinophils in health and disease.
Furuta GT; Atkins FD; Lee NA; Lee JJ
Ann Allergy Asthma Immunol; 2014 Jul; 113(1):3-8. PubMed ID: 24795292
[TBL] [Abstract][Full Text] [Related]
2. Mepolizumab use: Post-approval academic practice experience.
Benjamin MR; Bochner BS; Peters AT
Ann Allergy Asthma Immunol; 2018 Jul; 121(1):126-128. PubMed ID: 29653234
[No Abstract] [Full Text] [Related]
3. Eosinophils in mucosal immune responses.
Travers J; Rothenberg ME
Mucosal Immunol; 2015 May; 8(3):464-75. PubMed ID: 25807184
[TBL] [Abstract][Full Text] [Related]
4. Anti-interleukin-5 antibody therapy in eosinophilic diseases.
Simon D; Braathen LR; Simon HU
Pathobiology; 2005; 72(6):287-92. PubMed ID: 16582580
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic strategies for harnessing human eosinophils in allergic inflammation, hypereosinophilic disorders, and cancer.
Amini-Vaughan ZJ; Martinez-Moczygemba M; Huston DP
Curr Allergy Asthma Rep; 2012 Oct; 12(5):402-12. PubMed ID: 22875242
[TBL] [Abstract][Full Text] [Related]
6. [Anti-interleukin-5 therapy for eosinophilic diseases].
Simon D; Braathen LR; Simon HU
Hautarzt; 2007 Feb; 58(2):122, 124-7. PubMed ID: 17221241
[TBL] [Abstract][Full Text] [Related]
7. Eosinophils express functional IL-13 in eosinophilic inflammatory diseases.
Schmid-Grendelmeier P; Altznauer F; Fischer B; Bizer C; Straumann A; Menz G; Blaser K; Wüthrich B; Simon HU
J Immunol; 2002 Jul; 169(2):1021-7. PubMed ID: 12097410
[TBL] [Abstract][Full Text] [Related]
8. Functional CD137 receptors are expressed by eosinophils from patients with IgE-mediated allergic responses but not by eosinophils from patients with non-IgE-mediated eosinophilic disorders.
Heinisch IV; Bizer C; Volgger W; Simon HU
J Allergy Clin Immunol; 2001 Jul; 108(1):21-8. PubMed ID: 11447378
[TBL] [Abstract][Full Text] [Related]
9. Treatment of hypereosinophilic syndrome and eosinophilic dermatitis with reslizumab.
Kuruvilla M
Ann Allergy Asthma Immunol; 2018 Jun; 120(6):670-671. PubMed ID: 29496465
[No Abstract] [Full Text] [Related]
10. Targeting interleukin (IL) 5 for asthma and hypereosinophilic diseases.
Stein ML; Munitz A
Recent Pat Inflamm Allergy Drug Discov; 2010 Nov; 4(3):201-9. PubMed ID: 20807192
[TBL] [Abstract][Full Text] [Related]
11. Eosinophilic disorders in children.
Wagelie-Steffen A; Aceves SS
Curr Allergy Asthma Rep; 2006 Nov; 6(6):475-82. PubMed ID: 17026874
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-2 primes eosinophil degranulation in hypereosinophilia and Wells' syndrome.
Simon HU; Plötz S; Simon D; Seitzer U; Braathen LR; Menz G; Straumann A; Dummer R; Levi-Schaffer F
Eur J Immunol; 2003 Apr; 33(4):834-9. PubMed ID: 12672048
[TBL] [Abstract][Full Text] [Related]
13. Diagnoses associated with peripheral blood eosinophilia: A 5-year review.
Leverone N; Tran S; Barry J; Akuthota P
Ann Allergy Asthma Immunol; 2021 Nov; 127(5):597-598. PubMed ID: 34391899
[No Abstract] [Full Text] [Related]
14. Experimental Modeling of Eosinophil-Associated Diseases.
Upparahalli Venkateshaiah S; Manohar M; Kandikattu HK; Mishra A
Methods Mol Biol; 2021; 2241():275-291. PubMed ID: 33486743
[TBL] [Abstract][Full Text] [Related]
15. Biologics for the Treatment of Allergic Conditions: Eosinophil Disorders.
Olivieri B; Tinazzi E; Caminati M; Lunardi C
Immunol Allergy Clin North Am; 2020 Nov; 40(4):649-665. PubMed ID: 33012326
[TBL] [Abstract][Full Text] [Related]
16. 2021 year in review: Spotlight on eosinophils.
Dunn JLM; Rothenberg ME
J Allergy Clin Immunol; 2022 Feb; 149(2):517-524. PubMed ID: 34838883
[TBL] [Abstract][Full Text] [Related]
17. Eosinophils: changing perspectives in health and disease.
Rosenberg HF; Dyer KD; Foster PS
Nat Rev Immunol; 2013 Jan; 13(1):9-22. PubMed ID: 23154224
[TBL] [Abstract][Full Text] [Related]
18. High blood eosinophil counts predict sputum eosinophilia in patients with severe asthma.
Fowler SJ; Tavernier G; Niven R
J Allergy Clin Immunol; 2015 Mar; 135(3):822-4.e2. PubMed ID: 25445828
[No Abstract] [Full Text] [Related]
19. Quantification of the duodenal eosinophil content in adults: a necessary step for an evidence-based diagnosis of duodenal eosinophilia.
Genta RM; Sonnenberg A; Turner K
Aliment Pharmacol Ther; 2018 Apr; 47(8):1143-1150. PubMed ID: 29488232
[TBL] [Abstract][Full Text] [Related]
20. Mepolizumab in eosinophilic disorders.
Abonia JP; Putnam PE
Expert Rev Clin Immunol; 2011 Jul; 7(4):411-7. PubMed ID: 21790283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
